Hepatitis B Mapping Project
The Hepatitis B Mapping Project is a joint
initiative of ASHM and the Doherty Institute, funded by the Australian Government
Department of Health. The project will produce a comprehensive understanding of
chronic hepatitis B (CHB) in Australia using data that will help to inform
awareness and intervention campaigns to suit the particular local needs of
people living with CHB and those providing services to them.
NEW Second National Report: Estimates of chronic
hepatitis B diagnosis, monitoring and treatment by Medicare Local (released 04 Feb 2014)
For the first time, national datasets are used to indicate
the current level of diagnosis, monitoring and treatment, as well as
vaccination rates and outcomes of infection. The report serves as a benchmark against which progress in
achieving the National Hepatitis B Strategy 2014-2017 targets and priorities
can be assessed. It provides detailed information at a national,
state/territory and local area.
Download the Second National Hepatitis B Mapping Report
The First Hepatitis B Mapping Project National Report (released 2012)
This report outlines the comprehensive mapping phase of the
project, which identifies priority Medicare Locals based on CHB burden along
with the major communities affected in each of these areas as gleaned from the
2011 Census. The report presents the number of people living with CHB in each
Medicare Local and the proportion of the population that number represents;
what proportion of people living with CHB in each Medicare Local were born
overseas or are Aboriginal and Torres Strait Islander people; how many speak
little or no English; and the geographic breakdown within Medicare Locals according
to constituent Local Government Areas (LGAs).Download the Hepatitis
B Mapping Project: Estimates of chronic hepatitis B prevalence and
cultural and linguistic diversity by Medicare Local, 2011 National
Report (PDF 900kB): Focusing on baseline Medicare Local prevalence estimates and demographic and linguistic information.)
Why do we need to map
the extent of hepatitis B?
Around 218,000 people were estimated to be living with CHB
in Australia in 2011, approximately 1% of the population. In Australia,
people born overseas (particularly from Asia, the Pacific and Africa) and
Aboriginal and Torres Strait Islander people are disproportionately affected by
Due to these epidemiological determinants, CHB is not evenly
distributed geographically in Australia with wide variation by area.
Enhancing access to treatment and care, a priority action in
the National Hepatitis B Strategy, relies on people receiving information,
being diagnosed, and being able to access culturally appropriate and safe
How can the project
outputs be used?
Localised priority setting is a key objective of recent
healthcare reform in Australia, and the geographic mapping of the burden of
diseases such as CHB allows for the prioritisation of health interventions and
improvement of local service delivery in areas of the greatest need.
The geographically uneven distribution of CHB presents the
opportunity to engage with and improve awareness within affected communities
though the targeting of high prevalence areas. Additionally, identifying areas
where access to appropriate diagnosis and treatment is lowest relative to the
estimated burden of CHB and incidence of liver cancer provides the opportunity
to prioritise interventions and local service delivery.
It is planned to update these reports annually, to reflect
both the shifting epidemiology of CHB in Australia and evaluate the impact of
public health and clinical service interventions on increasing access to
diagnosis and treatment at a population level over time.
Who is behind the
Hepatitis B Mapping Project?
ASHM and the Doherty Institute are working in partnership to
produce a comprehensive understanding of the epidemiology of hepatitis B in
Australia. The Hepatitis B Mapping Project commenced in 2012 and is funded by
the Australian Government Department of Health.
Frequently asked questions on methodology